Literature DB >> 67547

Biosynthesis of thyroid hormone: basic and clinical aspects.

L J Degroot, H Niepomniszcze.   

Abstract

Thyroid hormone formation requires the coincident presence of peroxidase, H2O2, iodide, and acceptor protein at one anatomic locus in the cell. The peroxidase enzyme appears to be a protoporphyrin lX containing heme protein, with binding sites for both iodide and tyrosine. It is probable that both iodide and tyrosine are oxidized to free radical forms which unite to form iodotyrosine. The peroxidase is also involved through an uncertain mechanism in iodotyrosine coupling and probably in oxidation of sulfhydryl bonds in thyroglobulin. H2O2 may be supplied by microsomal NADPH-cytochrome c reductase or NADH-cytochrome b5 reductase. Other possible intracellular H2OI generating systems include monoamine oxidase and xanthine oxidase. The usual acceptor for iodide is thyroglobulin, which is currently believed to be iodinated within apical secretory vesicles at the cell border just prior to liberation into the colloid, or possibly after liberation into the colloid. Other soluble an insoluble proteins are also iodinated within the gland. The peroxidase is present in numerous cellular structures, but iodination activity occurs primarily, if not only, at the apical cell border. The controls of iodination are imperfectly known. Thyrotrophin modulation of iodide uptake, H2O2 generation, thyroglobulin synthesis, and peroxidase enzyme level obviously are the main regulations. Many of these actions are thought to involve mediation of adenyl cyclase and subsequent activation of intracellular phosphokinases. Antithyroid drugs of the thiocarbamide group are competitive inhibitors of iodination under some circumstances, but if much iodide is present, they react with the oxidized iodine intermediate and are irreversibly inactivated themselves. Clinical problems involving defective peroxidase function are among the most frequent hereditary defects of thyroid hormone formation. Recognized abnormalities include deficient peroxidase, abnormality in binding of the peroxidase apoprotein to its prosthetic group, and other less well-identified abnormalities in peroxidase structure and function. Peroxidase is typically elevated in thyroid tissue from patients with hyperthyroidism sometimes deficient in cold thyroid nodules, and frequently diminished in tissue from patients with Hashimoto's thyroiditis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67547     DOI: 10.1016/0026-0495(77)90088-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  20 in total

1.  [The fine structure of treated Graves' disease. Morphological alterations after preoperative therapy with iodide, thionamides and lithium (author's transl)].

Authors:  H Dralle; W Böcker; G Koch
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-31

2.  Improved assay method for activity of thyroid peroxidase-catalysed coupling of iodotyrosine residues of thyroglobulin utilizing h.p.l.c. for analysis of iodothyronines.

Authors:  T Ohmori; O Tarutani; T Hosoya
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Characterization of a thyroid-specific enhancer located 5.5 kilobase pairs upstream of the human thyroid peroxidase gene.

Authors:  F Kikkawa; F J Gonzalez; S Kimura
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

4.  Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat.

Authors:  Isabelle Becher; Thilo Werner; Carola Doce; Esther A Zaal; Ina Tögel; Crystal A Khan; Anne Rueger; Marcel Muelbaier; Elsa Salzer; Celia R Berkers; Paul F Fitzpatrick; Marcus Bantscheff; Mikhail M Savitski
Journal:  Nat Chem Biol       Date:  2016-09-26       Impact factor: 15.040

5.  Diffusion artefacts and tissue fixation in thyroperoxidase cytochemistry.

Authors:  T Ofverholm; L E Ericson
Journal:  Histochemistry       Date:  1984

6.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1.

Authors:  K Mizuno; F J Gonzalez; S Kimura
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  A quantitative study of peroxidase activity in unfixed tissue sections of the guinea-pig thyroid gland.

Authors:  P A Ealey; B Henderson; N Loveridge
Journal:  Histochem J       Date:  1984-02

Review 9.  Biochemistry of thyroid regulation under normal and abnormal conditions.

Authors:  M A Pisarev; D L Kleiman de Pisarev
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

10.  Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs.

Authors:  S Kimura; T Kotani; O W McBride; K Umeki; K Hirai; T Nakayama; S Ohtaki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.